Psychemedics Corp.

General ticker "PMD" information:

  • Sector: Health Care
  • Industry: Health Care Providers & Services
  • Capitalization: $14.2M

Psychemedics Corp. does not follow the US Stock Market performance with the rate: -29.4%.

Estimated limits based on current volatility of 8.0%: low 1.66$, high 1.95$

Factors to consider:

  • US accounted for 97.1% of revenue in the fiscal year ended 2022-12-31
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.75$, 4.42$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.81$, 4.39$]

Financial Metrics affecting the PMD estimates:

  • Negative: Non-GAAP EPS, $ of -0.72 <= 0.10
  • Negative: Operating profit margin, % of -11.68 <= 1.03
  • Negative: Operating cash flow per share per price, % of -8.37 <= 2.35
  • Negative: negative Net income
  • Positive: 3.85 < Industry operating cash flow per share per price (median), % of 5.45
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term PMD quotes

Long-term PMD plot with estimates

Financial data

YTD 2022-12-31 2023-12-31
Operating Revenue $25.24MM $22.10MM
Operating Expenses $26.32MM $25.02MM
Operating Income $-1.08MM $-2.92MM
Non-Operating Income $0.04MM $-0.52MM
R&D Expense $1.33MM $1.14MM
Income(Loss) $-1.04MM $-3.44MM
Taxes $0.04MM $0.72MM
Profit(Loss) $-1.08MM $-4.15MM
Stockholders Equity $-10.08MM $6.67MM
Assets $18.73MM $12.33MM
Operating Cash Flow $4.89MM $-1.48MM
Capital expenditure $0.19MM $0.16MM
Investing Cash Flow $-0.21MM $-0.16MM
Financing Cash Flow $-1.92MM $-1.15MM
Earnings Per Share* $-0.19 $-0.72

* EPS are Split Adjusted, recent splits may be reflected with a delay.